← Back to Search

Diabetes Management App for Diabetes (GEMApp Trial)

N/A

Waitlist Available

Research Sponsored by Marshall University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Type 1 or type 2 diabetes on therapeutic treatment other than just lifestyle changes

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

GEMApp Trial Summary

This trial is testing whether a phone app can help manage diabetes and improve A1C levels and quality of life.

Who is the study for?

This trial is for individuals with type 1 or type 2 diabetes who are under treatment by the Marshall Internal Medicine Department. Participants must have a smartphone and at least a sixth-grade education level. Pregnant women and those with cognitive impairments cannot join.Check my eligibility

What is being tested?

The study tests an app that gives instructions for managing blood sugar levels to see if it can improve diabetic care, reduce emergency room visits, better A1C levels (a measure of blood sugar control), and enhance quality of life compared to general advice.See study design

What are the potential side effects?

Since this trial involves using an app for glucose management guidance rather than medication, there are no direct medical side effects. However, potential issues may include stress or confusion from app usage.

GEMApp Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am being treated for diabetes with medication, not just diet or exercise.

GEMApp Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of hypoglycemic episodes

Secondary outcome measures

A1c level

ADDQOL score

Number of Emergency Room, Urgent Care, or Walk-In Clinic visits

GEMApp Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Functioning AppExperimental Treatment1 Intervention

These subjects have the complete algorithm functioning and communicated via the App.

Group II: Non-functioning AppPlacebo Group1 Intervention

These subjects receive routine instructions via the App but not the complete algorithm.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Marshall UniversityLead Sponsor

20 Previous Clinical Trials

4,122 Total Patients Enrolled

Media Library

Experimental Group instructions for glucose management via App Clinical Trial Eligibility Overview. Trial Name: NCT02336217 — N/A

Diabetes Research Study Groups: Non-functioning App, Functioning App

Diabetes Clinical Trial 2023: Experimental Group instructions for glucose management via App Highlights & Side Effects. Trial Name: NCT02336217 — N/A

Experimental Group instructions for glucose management via App 2023 Treatment Timeline for Medical Study. Trial Name: NCT02336217 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the scope of the research limited to participants aged 35 and over?

"Participants in this medical trial must be of legal age (18+) and not past their prime (70 years old). For those who do not meet these conditions, there are 225 trials for minors and 1032 studies dedicated to seniors."

Answered by AI

Are there still opportunities to enrol in this research study?

"According to the clinicaltrials.gov records, this particular trial is not presently recruiting patients; it was initially posted on September 1st 2014 and last modified on April 5th 2022. Nonetheless, there are a multitude of other medical trials now inviting participants which total 1363 in number."

Answered by AI

Might I be eligible to contribute to this medical experiment?

"The requirements for entry into this trial are to be 18-70 years old, and have a pre-existing diagnosis of diabetes mellitus. 40 patients will eventually be enrolled in the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations

Henry Driscoll, MD 2014. "Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02336217.